Abstract
Protein-protein interactions have a key role in transduction pathways that regulate many cellular functions. Structural and functional properties of protein-protein interface are now better understood, therefore offering attractive opportunities for therapeutic intervention. Developping small molecules that modulate protein-protein interactions is challenging. Nethertheless, significant progress in this endeavour has been made on several fronts. Here, we use few illustrative examples to summarize recent work in this emerging field.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Apoptosis Regulatory Proteins
-
Computer Simulation
-
Drug Design*
-
Drug Evaluation, Preclinical
-
Fluorescence Resonance Energy Transfer
-
Humans
-
Intracellular Signaling Peptides and Proteins / drug effects
-
Intracellular Signaling Peptides and Proteins / metabolism
-
Mitochondrial Proteins / drug effects
-
Mitochondrial Proteins / metabolism
-
Models, Molecular
-
Protein Binding / drug effects*
-
Protein Conformation / drug effects
-
Protein Interaction Mapping / methods
-
Proto-Oncogene Proteins c-bcl-2 / drug effects
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Proto-Oncogene Proteins c-mdm2 / drug effects
-
Proto-Oncogene Proteins c-mdm2 / metabolism
-
Tumor Suppressor Protein p53 / drug effects
-
Tumor Suppressor Protein p53 / metabolism
-
User-Computer Interface
-
X-Linked Inhibitor of Apoptosis Protein / drug effects
-
X-Linked Inhibitor of Apoptosis Protein / metabolism
-
bcl-2-Associated X Protein / drug effects
-
bcl-2-Associated X Protein / metabolism
Substances
-
Apoptosis Regulatory Proteins
-
BAX protein, human
-
DIABLO protein, human
-
Intracellular Signaling Peptides and Proteins
-
Mitochondrial Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
Tumor Suppressor Protein p53
-
X-Linked Inhibitor of Apoptosis Protein
-
XIAP protein, human
-
bcl-2-Associated X Protein
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2